VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2020

Apr 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2020-04-24

Reporting Person: Lee Yuchun (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-24	Common Stock	M	2000	$57.27	Acquired	3875	Direct
2020-04-24	Common Stock	S	890	$267.23	Disposed	2985	Direct
2020-04-24	Common Stock	S	590	$268.31	Disposed	2395	Direct
2020-04-24	Common Stock	S	400	$269.28	Disposed	1995	Direct
2020-04-24	Common Stock	S	120	$270.30	Disposed	1875	Direct
2020-04-27	Common Stock	M	2000	$57.27	Acquired	3875	Direct
2020-04-27	Common Stock	S	193	$268.40	Disposed	3682	Direct
2020-04-27	Common Stock	S	394	$270.37	Disposed	3288	Direct
2020-04-27	Common Stock	S	1113	$271.56	Disposed	2175	Direct
2020-04-27	Common Stock	S	200	$272.51	Disposed	1975	Direct
2020-04-27	Common Stock	S	100	$273.44	Disposed	1875	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-24	Stock Option (Right to Buy)	$57.27	M	2000	Disposed	2022-09-13	Common Stock (2000)	Direct
2020-04-27	Stock Option (Right to Buy)	$57.27	M	2000	Disposed	2022-09-13	Common Stock (2000)	Direct

Footnotes

F1: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2: Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.72 to $267.71).

F3: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4: Open market sales reported on this line occurred at a weighted average price of $268.31 (range $267.94 to $268.77).

F5: Open market sales reported on this line occurred at a weighted average price of $269.28 (range $269.00 to $269.64).

F6: Open market sales reported on this line occurred at a weighted average price of $270.30 (range $270.05 to $270.33).

F7: Open market sales reported on this line occurred at a weighted average price of $268.40 (range $268.05 to $268.77).

F8: Open market sales reported on this line occurred at a weighted average price of $270.37 (range $270.08 to $270.78).

F9: Open market sales reported on this line occurred at a weighted average price of $271.56 (range $271.12 to $272.00).

F10: Open market sales reported on this line occurred at a weighted average price of $272.51 (range $272.31 to $272.71).

F11: Fully vested.